GoodRx, LifeMD gains on Wegovy pill offerings (LFMD:NASDAQ)

Group 1 - LifeMD (LFMD) and GoodRx (GDRX) shares increased in premarket trading following the announcement of Novo Nordisk's (NVO) Wegovy pill availability in their product offerings [2] - The announcement from the Danish drugmaker indicates a strategic partnership that could enhance the market presence of both LifeMD and GoodRx [2] - Wegovy is positioned as a significant product in the weight management sector, reflecting the growing demand for obesity treatments [2]